Volume 152, Issue 1, Pages (January 2019)

Slides:



Advertisements
Similar presentations
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Advertisements

Volume 144, Issue 1, Pages (January 2017)
Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery  David Palma, Otto.
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Volume 60, Issue 2, Pages (August 2011)
Volume 148, Issue 1, Pages (January 2018)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Volume 148, Issue 1, Pages (January 2018)
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 148, Issue 1, Pages (January 2018)
Volume 145, Issue 2, Pages (May 2017)
Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
Volume 131, Issue 1, Pages 8-14 (October 2013)
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells
M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns
Volume 151, Issue 1, Pages (October 2018)
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe  Yukinori Sakao,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Pulmonary Resection for Metastatic Gastric Cancer
National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence  J. Chino, J.R. Foote,
Volume 146, Issue 1, Pages (July 2017)
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 152, Issue 1, Pages (January 2019)
Volume 152, Issue 1, Pages (January 2019)
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Volume 143, Issue 2, Pages (November 2016)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Volume 152, Issue 1, Pages (January 2019)
Volume 152, Issue 1, Pages (January 2019)
Medical Care for Refugee Patients
Volume 152, Issue 1, Pages (January 2019)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Volume 130, Issue 1, Pages (July 2013)
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 1, Pages (October 2017)
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Volume 152, Issue 1, Pages (January 2019)
Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.
Perineural invasion (PNI) in vulvar carcinoma: A review of 421 cases
Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer  Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,
Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD 
The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough  K.M. Doll, E.L. Barber, J.T. Bensen,
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study 
Volume 152, Issue 1, Pages (January 2019)
Volume 130, Issue 1, Pages (July 2013)
Full inguinofemoral lymphadenectomy after positive sentinel inguinofemoral lymph node is associated with greater overall survival in patients with stage.
Volume 152, Issue 1, Pages (January 2019)
Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival  Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,
Volume 151, Issue 1, Pages (October 2018)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Volume 130, Issue 1, Pages (July 2013)
Carcinoma of the esophagus: Prognostic significance of histologic type
Volume 152, Issue 1, Pages (January 2019)
Mert Saynak, MD, Jessica Hubbs, MS, Jiho Nam, MD, Lawrence B
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Volume 115, Issue 1, Pages (October 2009)
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

Volume 152, Issue 1, Pages 76-81 (January 2019) Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer  Sonia Prader, Nils Vollmar, Andreas du Bois, Florian Heitz, Stephanie Schneider, Beyhan Ataseven, Mareike Bommert, Kai-Uwe Waltering, Sebastian Heikaus, Jens Albrecht Koch, Pier Francesco Alesina, Alexander Traut, Philipp Harter  Gynecologic Oncology  Volume 152, Issue 1, Pages 76-81 (January 2019) DOI: 10.1016/j.ygyno.2018.11.001 Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 1 Patient flowchart. EOC: epithelial ovarian cancer, CPLN: Cardiophrenic lymph nodes. Gynecologic Oncology 2019 152, 76-81DOI: (10.1016/j.ygyno.2018.11.001) Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 2 Overall survival and progression free survival in completely resected patients (TR0) with Cardiophrenic lymph nodes (CPLN) <5 mm versus ≥5 mm. Gynecologic Oncology 2019 152, 76-81DOI: (10.1016/j.ygyno.2018.11.001) Copyright © 2018 Elsevier Inc. Terms and Conditions

Fig. 3 Overall survival and progression free survival for patients with resected (R+) cardiophrenic lymph nodes (CPLN) versus non resected (R−) CPLN in a matched pair comparison. Gynecologic Oncology 2019 152, 76-81DOI: (10.1016/j.ygyno.2018.11.001) Copyright © 2018 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.